Skip to content

NGEN

NervGen Pharma Corp.

NASDAQ · Healthcare · Biotechnology · CA

$1.54
−3.14%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
13.53x
Price / sales
—
Price / cash flow
-7.91x

Enterprise value

Enterprise value
$104.2M
EV / sales
—
EV / EBITDA
-12.68x
EV / EBIT
-3.87x
Market cap
$165.7M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026